Our CEO Anthony Finbow has been appointed Vice Chairman of the newly formed BIA (UK BioIndustry Association) Genomics Advisory Committee. The committee has been established to support the strategic objective that the UK starts, scales and builds world leading genomic businesses. The Committee will act as a leadership platform for sharing and discussing issues of common […]
Benefiting from an established pedigree the company already has the knowledge, customers and products in place and now the time is right for further expansion in the field of industrial data analytics and predictive science. Oslo, Norway – CAMO Software AS today appointed Raman Bhatnagar as the company’s new Chief Executive Officer. Raman is an […]
Eagle Genomics has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to become Chief Product Officer. The change in management structure marks a new phase for Eagle Genomics as the organisation rapidly shapes for scale to meet customer demand. The company has won 11 enterprise customers since its […]
RURO announced today that Stephen Ferrell CISA CRISC, formerly Vice President of Product Strategy at ByteGrid, will join RURO as its Chief Compliance Officer. Stephen’s background ensures that he will contribute valuable leadership to the company and also benefit RURO’s growing portfolio of products and services. Prior to his most recent position, Ferrell directed governance, […]
Alberto Mas to Lead Medical Segment;Patrick Kaltenbach to Lead Life Sciences Segment;Bill Tozzi to Lead Interventional Segment on Interim Basis FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced three executive appointments to the positions of segment president. Alberto Mas, 56, has been named president of […]
BILLERICA, Mass. — Bruker today announced the appointment of Dr. Falko Busse as President of the Bruker BioSpin Group, and as an executive officer of Bruker Corporation, effective as of May 1st, 2018. In his new role, Dr. Busse will have expanded responsibilities and oversight over the BioSpin Group, one of three key Scientific Instruments groups at the Company. […]
Dansky Ullmann joins the Company as MaxCyte prepares for clinical testing of its first cell therapy drug candidate Brings more than 25 years of experience in clinical oncology and drug development Gaithersburg, Maryland: MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in […]
SANTA CLARA, Calif. Highlights: Jacob Thaysen named President, Life Sciences and Applied Markets Group, moving from Agilent’s Diagnostics and Genomics Group Sam Raha appointed President, Diagnostics and Genomics Group, moving from Agilent Strategy and Corporate Development Agilent Technologies Inc. (NYSE: A) today announced that Jacob Thaysen, currently, senior vice president, Agilent and president, Diagnostics and […]
MINNEAPOLIS — Bio-Techne Corporation announced today that it has hired Kim Kelderman as President, Diagnostics and Genomics, effective April 30, 2018. Mr. Kelderman will be based in California and will lead Bio-Techne’s diagnostics business; he will also drive and develop our strategic initiatives in genomics and genomics-based diagnostics. With this appointment Mr. Kelderman will become an executive officer […]
Dr. Dreismann To Also Serve as Chairman of the Executive Advisory Board; Assist MyDx In Seeking Development Partners and Strategic Partners San Diego, CA — MyDx, Inc. (OTC: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to understand the chemical profile […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
